Viral protein mimic keeps immune system quiet

The work was performed in collaboration with W.R. Kenan, Jr. Distinguished Professor, Jenny Ting, PhD. First author, Sean Gregory, MS, a graduate student in UNC's Department of Microbiology and Immunology played a critical role in this work.

The virus-produced protein, called a homolog, binds to the cellular protein that normally triggers an inflammatory response, a key immune system weapon for fighting viral infection. However, the homolog lacks a key part of the cellular protein that triggers the inflammation process. Inflammasome activation leads to the production of proinflammatory cytokines and eventual cell death.

Damania compares the homolog's action to what can happen when completing a jigsaw puzzle. "Sometimes there will be a piece that 'almost' fits into an available space, but because it's not an exact fit, leaving it there will keep you from completing the puzzle. The viral homolog gums up the works, preventing the formation of a large complex called the inflammasome, and keeping the cell's immune response from deploying."

According to Damania, a cell's response to a viral invader is to commit suicide. The cells die rather than spread the virus, which uses the cell by hijacking its genetic machinery to produce more virus. Kaposi sarcoma virus' ability to evade the body's immune system helps it lie dormant and persist in the body over a lifetime.

Both researchers are members of UNC Lineberger Comprehensive Cancer Center. Dr. Damania studies the Kaposi's sarcoma virus, which is known to cause certain types of human cancer, because it can infect cells and lie dormant without triggering cellular death. Virus-infected cells then proliferate, and can give rise to cancer.

Damania and Ting's research collaborators include Sean Gregory, M.S., Beckley Davis, PhD, John West, PhD, and Debra Taxman, PhD, all of UNC Lineberger and the UNC Department of Microbiology and Immunology. Damania is also a member of the UNC Center for AIDS Research. Dr. Ting is the co-Director of the Inflammatory Disease Institute and Director of the Center for Translational Immunology. The team also included collaborators, John Reed, MD, and Shu-ichi Matsuzawa, PhD, both of the Sanford-Burnham Medical Research Institute in La Jolla, California.

The research was supported by the US National Institutes of Health, the University Cancer Research Fund, the American Heart Association, the Burroughs Wellcome Fund, and the Crohn's & Colitis Foundation of America. Damania is a Leukemia & Lymphoma Society Scholar and Burroughs Wellcome Fund Investigator in Infectious Disease.